EVAX Latest Headlines

Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE) and Evaxion Biotech (EVAX)

at www.tipranks.com (Mon, 8-Dec 8:50 AM)

Evaxion Unveils Promising Data for AML Vaccine at ASH Meeting

at www.tipranks.com (Mon, 8-Dec 6:50 AM)

Evaxion’s AI-Powered Vaccine Achieves 75% Objective Response Rate in Advanced Melanoma—Phase 2 Data Points to Durable and Safe Outcomes

Market Chameleon (Fri, 17-Oct 8:32 AM)

Evaxion Secures $7.5 Million from MSD for EVX-B3 Vaccine—Cash Runway Extended to 2027 and $592 Million Milestone Potential

Market Chameleon (Thu, 25-Sep 9:57 AM)

Evaxion Secures $7.5M from MSD in Major Vaccine Out-Licensing Deal—Milestones Could Reach $592 Million

Market Chameleon (Thu, 25-Sep 7:57 AM)